Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-29 @ 5:52 PM
Study NCT ID:
NCT05993858
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-15
First Post:
2023-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UHCT230527
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None